Insiders who reported open-market trades in the last 12 months at the companies Richard Ogawa files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Jeffrey B. Shealy - $1000K in PALX purchases and sales in the last 12 months
Steven Denbaars - $50K in PALX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Richard Ogawa is a corporate insider, tracked as General Counsel and Secretary, Director of Palomino Laboratories Inc. (PALX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Richard Ogawa submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Richard Ogawa been buying or selling stock?
Recorded transactions: 1 open-market purchase ($50K) and 1 open-market sale ($150K) across all tracked filings.
Richard Ogawa is General Counsel and Secretary, Director of Palomino Laboratories Inc. (PALX). 5 SEC Form 4 filings on record going back to 2024, most recently on 9 September 2026. Most recent open-market trade: bought $50K of PALX on 20 April 2026. Lifetime open-market purchases: $50K. Lifetime open-market sales: $150K.
Recent transactions
5
The latest 5 SEC Form 4 transactions reported by Richard Ogawa.
InsiderAlpha's records for Richard Ogawa go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. The typical open-market purchase is $50K (1 buy totaling $50K). The largest single buy on record is $50K of PALX in 2026. Sales side: 1 recorded sale totaling $150K, so the filing history runs sell-heavy by dollar value. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
